Wednesday, June 3  •  12:00 PM – 1:00PM EDT

Register for Webinar
Robert Zink

Claire M. Brennan
Section Chief, Liaison Section, Diversion Control Division
Drug Enforcement Administration

Scott A. Brinks
Section Chief Regulatory Drafting & Policy Support Section Diversion Control Division
Drug Enforcement Administration

Hunter DeKoninck
Attorney
Quarles & Brady LLP

Rick Hartunian
Partner
Manatt, Phelps & Phillips, LLP

Complimentary Webinar Highlights:

During this global pandemic, the Diversion Control Division is working to assure that there is an adequate supply of controlled substances in the United States, while preventing the diversion of these controlled substances.

To help every link of the supply chain understand DEA’s tools and role during these unprecedented times, we invite you to join this informative webinar to learn firsthand about the guidance documents and exceptions to regulations that DEA has issued.

Topics Include:

  • Reviewing DEA’s COVD-19 responses
  • Identifying challenges for suspicious order monitoring during the global pandemic
  • Overcoming due diligence road blocks during social distancing